20S Proteasome Core Particle Stimulators for Protein Degradation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for diseases associated with abnormal regulation of the ubiquitin-proteasome system (UPS) are inadequate, as the 20S core particle (CP) of the UPS has limited capacity for degrading potentially harmful proteins, leading to slow substrate entry and hydrolysis, which can interfere with normal cellular functions.
Innovation Solution
Development of specific 20S CP stimulator compounds, such as miconazole and its derivatives, which act as 'gate-openers' or enhance catalytic site activity, increasing the efficiency of protein degradation by stabilizing the open-gate state of the 20S CP and enhancing hydrolysis activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If chemical stimulators are used to enhance 20S CP activity, then protein degradation efficiency is improved, but substrate entry rate remains limited
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of stimulator compounds (Formula I with variables A, B, C representing different substituent groups) to optimize their ability to enhance 20S CP activity. By systematically varying molecular parameters such as substituent types and positions, the invention achieves improved protein degradation efficiency while addressing substrate entry limitations through structure-activity relationship optimization
Solution Approach 2:
The patent uses small molecule stimulators as intermediaries that bind to the 20S core particle and mediate enhanced substrate entry and degradation. These chemical mediators (compounds of Formula I) act as bridges between the substrate proteins and the 20S CP active sites, facilitating improved degradation kinetics without requiring the full 26S proteasome complex
2Productivity
If 20S CP is used for protein degradation, then degradation capacity is improved, but hydrolysis activity is slow
Solution Approach 1:
The patent employs parameter changes by developing a series of chemical compounds (Formula I with varying A, B, C substituents) that specifically enhance the hydrolysis activity of 20S CP. The structural variations in the stimulator molecules allow optimization of catalytic enhancement while maintaining the inherent degradation capacity of the 20S core particle
Solution Approach 2:
The patent applies dynamics by using stimulator compounds that induce conformational changes in the 20S core particle to enhance hydrolysis activity. The chemical stimulators dynamically modulate the gate opening and active site accessibility, allowing the 20S CP to transition between different functional states that optimize both substrate entry and hydrolysis rates
Data Source
AI summary
This present disclosure relates to series compounds and methods of use for the treatment of a disease caused by abnormal regulation of the ubiquitin-proteasome system (UPS), and wherein said compound is an effective stimulator of the 20S core particle (CP) of the UPS. Composition matters and methods of uses are within the scope of this disclosure.